Intellectual Property
Licensing
The Licensing department’s lawyers have a thorough understanding of the dynamics of deal-making and are familiar with the issues arising in the entire spectrum of licensing transactions, making them well-equipped to counsel clients on “best practices” and industry standards.
The department’s scope of work includes drafting and negotiating agreements for research and development, licensing, manufacturing, distribution, sale, branding, marketing, consulting and other forms of commercial exploitation of intellectual property, generating revenue and establishing strategic partnerships.
Covering a wide range of industries, the Licensing department’s clients include local and international software, semiconductor, biotechnology, pharmaceutical, medical devices, multi-media, entertainment, content companies and other Hi-Tech companies.
Licensing News & Insights
Our team is looking forward to 2024, and we are confident that our new partners, the majority of whom are
We are happy to introduce our new partners
We are delighted to announce that in this year’s BDICode ranking, we are ranked in the top-tier in no less
Herzog is ranked by BDi Code as the top tier in 38 practice areas for 2023
Happy Holidays! Wishing you and your loved ones health and happiness in the new year. May 2023 be an extraordinary
Happy Holidays !
888 has entered into a license agreement to use the Sports Illustrated brand, opening its gambling services to new potential
Our client 888 has entered into a license agreement to use the Sports Illustrated brand
We want to thank you all for tackling the challenges of 2020 with us and hope that in 2021 we
Have a Happy and Healthy New Year 2021
As you know, Israel continues its efforts to deal with the Corona Virus and contain it, to avoid its spreading
Handling the Corona Virus- Live Updates
Designers, creators, inventors, and developers often find it necessary to prove that their own creation predates that of others: who
Client Update | WIPO PROOF
Herzog Fox & Neeman Partners Yair Geva, Tomer Farkash, Dan Sharot, and Ofer Granot, together with Associate Michal Shirin, represented Israeli biopharmaceutical company Entera Bio
Herzog Fox & Neeman Represents Entera Bio in $270m Amgen Licensing Deal
The Israeli Innovation Authority (IIA), formerly known as the OCS, has published important new rules for multinational corporations regarding licensing of
Client Update | The Israeli Innovation Authority’s New Special Licensing Rules for Multinational Corporations
Herzog Fox & Neeman partners Meir Linzen and Yehoshua Shohat Gurtler wrote the Law and Practice chapter in the 2018
Chambers Gaming, Gambling & Licensing Guide 2018 | Law & Practice Chapter by Meir Linzen and Yehoshua Shohat Gurtler
Dear Clients and Friends, The Israeli Innovation Authority (previously known as the Office of the Chief Scientist of the Israeli
Client Update | Announcing the IIA / OCS New Licensing Rules
We will be glad to assist you. Please fill in the following form
* required field
